Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Relay Medical

CNSX:RELA
Snowflake Description

Imperfect balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
RELA
CNSX
CA$37M
Market Cap
  1. Home
  2. CA
  3. Healthcare
Company description

Relay Medical Corp. develops and sells products in the medical device, consumer health, and health IT industries. The last earnings update was 30 days ago. More info.


Add to Portfolio Compare Print
RELA Share Price and Events
7 Day Returns
22.2%
CNSX:RELA
-3.8%
CA Medical Equipment
-4.8%
CA Market
1 Year Returns
7.3%
CNSX:RELA
-0.4%
CA Medical Equipment
0.1%
CA Market
RELA Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Relay Medical (RELA) 22.2% 18.9% 10% 7.3% -4.3% -
CA Medical Equipment -3.8% 6.3% 35.8% -0.4% -26.5% -31.6%
CA Market -4.8% -3.2% -1% 0.1% 2.7% 10.3%
1 Year Return vs Industry and Market
  • RELA outperformed the Medical Equipment industry which returned -0.4% over the past year.
  • RELA outperformed the Market in Canada which returned 0.1% over the past year.
Price Volatility
RELA
Industry
5yr Volatility vs Market

RELA Value

 Is Relay Medical undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Relay Medical. This is due to cash flow or dividend data being unavailable. The share price is CA$0.22.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Relay Medical's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Relay Medical's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:RELA PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in CAD CA$-0.07
CNSX:RELA Share Price ** CNSX (2020-02-27) in CAD CA$0.22
North America Medical Equipment Industry PE Ratio Median Figure of 64 Publicly-Listed Medical Equipment Companies 45.31x
Canada Market PE Ratio Median Figure of 509 Publicly-Listed Companies 15.2x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Relay Medical.

CNSX:RELA PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:RELA Share Price ÷ EPS (both in CAD)

= 0.22 ÷ -0.07

-3.2x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Relay Medical is loss making, we can't compare its value to the North America Medical Equipment industry average.
  • Relay Medical is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Relay Medical's expected growth come at a high price?
Raw Data
CNSX:RELA PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -3.2x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
North America Medical Equipment Industry PEG Ratio Median Figure of 57 Publicly-Listed Medical Equipment Companies 2.52x
Canada Market PEG Ratio Median Figure of 246 Publicly-Listed Companies 1.05x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Relay Medical, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Relay Medical's assets?
Raw Data
CNSX:RELA PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in CAD CA$0.01
CNSX:RELA Share Price * CNSX (2020-02-27) in CAD CA$0.22
Canada Medical Equipment Industry PB Ratio Median Figure of 14 Publicly-Listed Medical Equipment Companies 3.88x
Canada Market PB Ratio Median Figure of 2,345 Publicly-Listed Companies 1.35x
CNSX:RELA PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:RELA Share Price ÷ Book Value per Share (both in CAD)

= 0.22 ÷ 0.01

19.5x

* Primary Listing of Relay Medical.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Relay Medical is overvalued based on assets compared to the CA Medical Equipment industry average.
X
Value checks
We assess Relay Medical's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Relay Medical has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

RELA Future Performance

 How is Relay Medical expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Relay Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
64.5%
Expected Medical Equipment industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Relay Medical expected to grow at an attractive rate?
  • Unable to compare Relay Medical's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Relay Medical's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare Relay Medical's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:RELA Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 64.5%
North America Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 7.7%
Canada Market Earnings Growth Rate Market Cap Weighted Average 9.8%
Canada Market Revenue Growth Rate Market Cap Weighted Average 4.7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:RELA Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:RELA Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-09-30 -4 -8
2019-06-30 -8 -6
2019-03-31 -5 -7
2018-12-31 -4 -8
2018-09-30 -4 -8
2018-06-30 1 -8
2018-03-31 -2 -6
2017-12-31 -2 -5
2017-09-30 -2 -4
2017-06-30 -2 -3
2017-03-31 -2 -3
2016-12-31 -1 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Relay Medical is high growth as no earnings estimate data is available.
  • Unable to determine if Relay Medical is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:RELA Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Relay Medical Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:RELA Past Financials Data
Date (Data in CAD Millions) EPS *
2019-09-30 -0.07
2019-06-30 -0.05
2019-03-31 -0.06
2018-12-31 -0.08
2018-09-30 -0.09
2018-06-30 -0.09
2018-03-31 -0.08
2017-12-31 -0.07
2017-09-30 -0.06
2017-06-30 -0.05
2017-03-31 -0.05
2016-12-31 -0.04

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Relay Medical will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of RELA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. Relay Medical's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. Relay Medical's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Relay Medical's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the North America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Relay Medical has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

RELA Past Performance

  How has Relay Medical performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Relay Medical's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Relay Medical does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Relay Medical's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Relay Medical's 1-year growth to the North America Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
Relay Medical's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Relay Medical Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:RELA Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 -8.02 4.01 0.91
2019-06-30 -6.11 4.06 0.87
2019-03-31 -6.62 4.74 0.36
2018-12-31 -7.62 5.82 0.35
2018-09-30 -8.10 6.53 0.22
2018-06-30 -7.52 6.22 0.12
2018-03-31 -6.31 5.39
2017-12-31 -4.68 3.66 0.03
2017-09-30 -3.88 2.99
2017-06-30 -3.21 1.94
2017-03-31 -2.71 1.40
2016-12-31 -2.40 1.41
2016-09-30 -1.76 0.88
2016-06-30 -1.46 1.17
2016-03-31 -1.64 1.33
2015-12-31 -1.76 1.43
2015-09-30 -2.09 1.75
2015-06-30 -2.31 1.88
2015-03-31 -2.75 1.74
2014-12-31 -2.31 1.38
2014-09-30 -1.65 0.80
2013-12-31 0.00 0.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Relay Medical has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Relay Medical has efficiently used its assets last year compared to the North America Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Relay Medical improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Relay Medical's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Relay Medical has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

RELA Health

 How is Relay Medical's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Relay Medical's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Relay Medical's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Relay Medical's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Relay Medical's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Relay Medical has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Relay Medical Company Filings, last reported 4 months ago.

CNSX:RELA Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 1.41 0.00 0.21
2019-06-30 4.26 0.00 0.62
2019-03-31 4.42 0.00 0.37
2018-12-31 5.49 0.00 1.22
2018-09-30 6.77 0.00 2.30
2018-06-30 5.39 0.00 1.10
2018-03-31 2.67 0.00 1.17
2017-12-31 3.10 0.00 1.46
2017-09-30 2.11 0.00 0.48
2017-06-30 2.60 0.00 0.75
2017-03-31 2.61 0.01 0.53
2016-12-31 2.37 0.00 0.23
2016-09-30 2.14 0.10 0.01
2016-06-30 2.90 0.00 0.03
2016-03-31 3.14 0.00 0.13
2015-12-31 3.34 0.01 0.24
2015-09-30 3.30 0.01 0.10
2015-06-30 2.81 0.04 0.00
2015-03-31 2.89 0.01
2014-12-31 3.29 0.00 0.15
2014-09-30 1.79 0.00 0.32
2013-12-31 0.03 0.00 0.01
  • Relay Medical has no debt.
  • Relay Medical currently has no debt however we can't compare to 5 years ago as we have no data for that period.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Relay Medical has less than a year of cash runway based on current free cash flow.
  • Relay Medical has less than a year of cash runway if free cash flow continues to grow at historical rates of 35.5% each year.
X
Financial health checks
We assess Relay Medical's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Relay Medical has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

RELA Dividends

 What is Relay Medical's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Relay Medical dividends.
If you bought CA$2,000 of Relay Medical shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Relay Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Relay Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:RELA Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 21 Stocks 1.2%
Canada Market Average Dividend Yield Market Cap Weighted Average of 335 Stocks 3.6%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.1%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Relay Medical has not reported any payouts.
  • Unable to verify if Relay Medical's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Relay Medical's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Relay Medical has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Relay Medical's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Relay Medical afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Relay Medical has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

RELA Management

 What is the CEO of Relay Medical's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Lahav Gil
COMPENSATION CA$326,560
TENURE AS CEO 2.1 years
CEO Bio

Mr. Lahav Gil is Chief Executive Officer and Director at Relay Medical Corp. since January 2018. Mr. Gil serves as Vice President of Innovation at StarFish Product Engineering Inc. Mr. Gil has been Chief Executive Officer & Director of ChroMedX Corp. since January 2018. He founded the Toronto based Kangaroo Group, Inc. and was its Chief Executive Officer. He has deep experience in Medtech product development and business. He has founded/co-founded 6 companies and has accompanied many Canadian start-ups on their journey from napkin to launch, critically contributing to their investability, clinical and market readiness. He has contributed to over 200 technology product launches and to game-changing innovations for companies such as: IMRIS, FIO, fSona, Cellaegis, XOR Labs Inc., Ultrasonix, Exact Imaging, Sciex, and others. He was Vice President of Product Development at XOR Labs Inc.

CEO Compensation
  • Insufficient data for Lahav to compare compensation growth.
  • Lahav's remuneration is higher than average for companies of similar size in Canada.
Management Team Tenure

Average tenure of the Relay Medical management team in years:

2.1
Average Tenure
  • The tenure for the Relay Medical management team is about average.
Management Team

Gerard Edwards

TITLE
Executive Chairman

Lahav Gil

TITLE
CEO & Director
COMPENSATION
CA$327K
TENURE
2.1 yrs

W. Kent

TITLE
President
COMPENSATION
CA$211K
TENURE
2.1 yrs

Ash Kaushal

TITLE
Consultant
TENURE
2.1 yrs

Chris Hopkins

TITLE
Chief Financial Officer
COMPENSATION
CA$16K
AGE
55
TENURE
5.6 yrs

Jessica Kuhn

TITLE
Director of Operations
TENURE
2.1 yrs

Igal Roytblat

TITLE
Chief Technology Officer
TENURE
1.9 yrs

Tom Glawdel

TITLE
Chief Scientific Officer
TENURE
1.7 yrs

Moshe Katzenelson

TITLE
Senior Vice President of Global Business Development
TENURE
0.7 yrs
Board of Directors Tenure

Average tenure of the Relay Medical board of directors in years:

2.8
Average Tenure
  • The average tenure for the Relay Medical board of directors is less than 3 years, this suggests a new board.
Board of Directors

Lahav Gil

TITLE
CEO & Director
COMPENSATION
CA$327K
TENURE
2.1 yrs

Mike Minder

TITLE
Independent Director
COMPENSATION
CA$40K
TENURE
5.6 yrs

Gerard Edwards

TITLE
Executive Chairman

Cynthia Balion

TITLE
Member of Technical Advisory Board
TENURE
5.3 yrs

Robert Smyth

TITLE
Member of Technical Advisory Board
TENURE
4.9 yrs

Brian Cameron

TITLE
Member of Advisory Board
TENURE
2.8 yrs

John Ormston

TITLE
Member of Advisory Board
AGE
52
TENURE
2.8 yrs

Greg Falck

TITLE
Member of Advisory Board
TENURE
2.8 yrs

Sid Thomas

TITLE
Independent Director
TENURE
0.8 yrs

Medhanie Tekeste

TITLE
Independent Director
TENURE
0.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
11. Jun 19 Buy W. Kent Individual 06. Jun 19 06. Jun 19 48,500 CA$0.19 CA$9,215
X
Management checks
We assess Relay Medical's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Relay Medical has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

RELA News

Simply Wall St News

Need To Know: Relay Medical Corp. (CNSX:RELA) Insiders Have Been Buying Shares

Relay Medical Insider Transactions Over The Last Year. … In the last twelve months, the biggest single purchase by an insider was when CEO & Director Lahav Gil bought CA$942k worth of shares at a price of CA$0.36 per share. … That means that even when the share price was higher than CA$0.20 (the recent price), an insider wanted to purchase shares

Simply Wall St -

Who Has Been Buying Relay Medical Corp. (CNSX:RELA) Shares?

So we'll take a look at whether insiders have been buying or selling shares in Relay Medical Corp. … But logic dictates you should pay some attention to whether insiders are buying or selling shares. … In the last twelve months there was more buying than selling by Relay Medical insiders

Simply Wall St -

Before You Buy Relay Medical Corp (CNSX:RELA), Consider Its Volatility

Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. … Beta is a widely used metric to measure a stock's exposure to market risk (volatility). … A stock with a beta greater than one is more sensitive to broader market movements than a stock with a beta of less than one.

Simply Wall St -

How Should You Think About Relay Medical Corp's (CNSX:RELA) Risks?

If you are looking to invest in Relay Medical Corp’s (CNSX:RELA), or currently own the stock, then you need to understand its beta in order to understand how it can affect the risk of your portfolio. … The second type is market risk, one that you cannot diversify away, since it arises from macroeconomic factors which directly affects all the stocks in the market. … A widely-used metric to measure a stock's market risk is beta, and the broad market index represents a beta value of one.

Simply Wall St -

RELA Company Info

Description

Relay Medical Corp. develops and sells products in the medical device, consumer health, and health IT industries. It provides HemoPalm, a handheld blood analyzer and single-use cartridge system for point-of-care blood gas and CO-oximetry testing; and Pharmatrac, an AI and data analytics driven personal medication management system for non-adherence to treatment. It also provides products and services related to the management of decentralized fleets of medical devices, and the data streams. The company was formerly known as ChroMedX Corp. and changed its name to Relay Medical Corp. in June 2018. Relay Medical Corp. is headquartered in Toronto, Canada.

Details
Name: Relay Medical Corp.
RELA
Exchange: CNSX
Founded:
CA$37,036,658
168,348,446
Website: http://www.relaymedical.com
Address: Relay Medical Corp.
401 Bay Street,
Suite 1600,
Toronto,
Ontario, M5H 2Y4,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX RELA New Common Shares Canadian National Stock Exchange CA CAD 12. Oct 2006
DB EIY2 New Common Shares Deutsche Boerse AG DE EUR 12. Oct 2006
Number of employees
Current staff
Staff numbers
0
Relay Medical employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/02/28 02:20
End of day share price update: 2020/02/27 00:00
Last earnings filing: 2020/01/29
Last earnings reported: 2019/09/30
Last annual earnings reported: 2019/09/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.